Graham Bayly

660 total citations
20 papers, 190 citations indexed

About

Graham Bayly is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Graham Bayly has authored 20 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Economics and Econometrics. Recurrent topics in Graham Bayly's work include Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Graham Bayly is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Graham Bayly collaborates with scholars based in United Kingdom and Russia. Graham Bayly's co-authors include Colin Dayan, Ponnusamy Saravanan, Julian Hamilton‐Shield, Aidan Searle, William A. Bartlett, Fiona E. Lithander, Frances L. Game, A.F. Jones, Rachel Perry and Elaine Wainwright and has published in prestigious journals such as The Lancet, Atherosclerosis and BMJ Open.

In The Last Decade

Graham Bayly

18 papers receiving 183 citations

Peers

Countries citing papers authored by Graham Bayly

Since Specialization

Citations

This map shows the geographic impact of Graham Bayly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham Bayly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham Bayly more than expected).

Fields of papers citing papers by Graham Bayly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham Bayly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham Bayly. The network helps show where Graham Bayly may publish in the future.

Co-authorship network of co-authors of Graham Bayly

This figure shows the co-authorship network connecting the top 25 collaborators of Graham Bayly. A scholar is included among the top collaborators of Graham Bayly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham Bayly. Graham Bayly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reducing cardiovascular disease risk among families with familial hypercholesterolaemia by improving diet and physical activity: a randomised controlled feasibility trial 2020 ·BMJ Open ·(unknown), Fiona E. Lithander, Aidan Searle, Graham Bayly, Christina Wei, David J. Stensel, Alice E. Thackray, Linda Hunt, Julian Hamilton‐Shield	6
2	Nutrition and physical activity intervention for families with familial hypercholesterolaemia: protocol for a pilot randomised controlled feasibility study 2020 ·Pilot and Feasibility Studies ·(unknown), Julian Hamilton‐Shield, David J. Stensel, Graham Bayly, Aidan Searle, Alice E. Thackray, Fiona E. Lithander	4
3	A case of severe hypercholesterolaemia and hypertriglyceridaemia in an adult leukaemia patient treated with pegaspargase 2020 ·Atherosclerosis ·(unknown), Andrew S. Day, Graham Bayly	0
4	Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis 2019 ·BMJ Open ·(unknown), Elaine Wainwright, Rachel Perry, Fiona E. Lithander, Graham Bayly, Alyson Huntley, (unknown), Julian Hamilton‐Shield, Aidan Searle	43
5	Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989–2017 2019 ·Atherosclerosis ·Alison Pottle, Gilbert R. Thompson, Mahmoud Barbir, Graham Bayly, Jaimini Cegla, Robert Cramb, (unknown), Ruth Eatough, (unknown), Clare Neuwirth, (unknown), Jules Payne, (unknown), Handrean Soran, Shahenaz Walji, (unknown), (unknown), D. Datta	21
6	Age Adjusted Welsh Criteria For Selecting Patients For Familial Hypercholesterolaemia (Fh) Genetic Testing 2019 ·Atherosclerosis Supplements ·(unknown), Ian McDowell, (unknown), Graham Bayly, (unknown), Charles B. Sherman, (unknown), Pauline Ashfield‐Watt	1
7	Serum neuron-specific enolase measurement for neuro-prognostication post out-of-hospital cardiac arrest: Determination of the optimum testing strategy in routine clinical use 2019 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·(unknown), Frances T. Palmer, (unknown), Agnieszka Skorko, Graham Bayly	1
8	A comparison of Simon Broome and welsh criteria for selecting patients for familial hypercholesterolaemia (FH) genetic testing 2018 ·Atherosclerosis ·Pauline Ashfield‐Watt, (unknown), I.F.W. McDowell, Graham Bayly, (unknown)	0
9	Genetic testing for Familial Hypercholesterolaemia in the genomic era. The utility of an NGS test for monogenic and polygenic hypercholesterolaemia 2017 ·Atherosclerosis Supplements ·(unknown), (unknown), (unknown), P. Dean, (unknown), Geoff Woodward, (unknown), Richard C. Moore, Steve E. Humphries, Graham Bayly, Maggie Williams	1
10	4 years' cascade genetic testing for familial hypercholesterolaemia in England – Increased referrals and ascertainment 2016 ·Atherosclerosis ·Alison Hills, (unknown), (unknown), Carol Robinson, Graham Bayly, Andrew M. Taylor, Mahmoud Barbir, (unknown), Melanie Watson, Nigel Wheeldon, (unknown)	1
11	The impact of routine next generation sequencing testing for familial hypercholesterolaemia – 5 months service experience 2014 ·Atherosclerosis ·(unknown), P. Dean, Siobhan O’Shea, (unknown), Graham Bayly, Andrew M. Taylor, A. Day, Melanie Watson, (unknown), Ruth M Ayling, (unknown), Sharon D. Whatley, I.F.W. McDowell, M. Williams	5
12	Serial high-sensitivity troponin measurements for the rapid exclusion of acute myocardial infarction in low-risk patients 2012 ·Emergency Medicine Journal ·Charlotte Dawson, Jonathan Benger, Graham Bayly	2
13	A double heterozygote for familial hypercholesterolaemia and familial defective apolipoprotein B-100 2010 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·Alison Taylor, Graham Bayly, (unknown), (unknown), Maggie Williams, Julian Hamilton‐Shield, Steve E. Humphries, Gail Norbury	15
14	Reproducibility of individualized coronary heart disease risk calculations in patients with diabetes mellitus 2002 ·Diabetic Medicine ·(unknown), (unknown), Andrew Day, Graham Bayly, Colin Dayan	1
15	Whose normal thyroid function is better—yours or mine? 2002 ·The Lancet ·Colin Dayan, Ponnusamy Saravanan, Graham Bayly	46
16	HDL-cholesterol and cardiac disease: which table to use? 2002 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·Graham Bayly	1
17	Practical implications of in vitro stability of cardiac markers 2001 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·(unknown), Graham Bayly, Andrew Day	10
18	Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus 2001 ·Diabetes Obesity and Metabolism ·Frances L. Game, William A. Bartlett, Graham Bayly, A.F. Jones	13
19	Laboratory‐based calculation of coronary heart disease risk in a hospital diabetic clinic 1999 ·Diabetic Medicine ·Graham Bayly, William A. Bartlett, P.H. O'Connor Davies, David Husband, (unknown), Frances L. Game, A.F. Jones	17
20	A Non-Isotopic Method for Estimating 11β Hydroxysteroid Dehydrogenase Activity In Vivo 1997 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·Graham Bayly, William A. Bartlett, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact